NORTH READING, Mass., Aug. 22, 2019 /PRNewswire/ — TraceLink Inc., the world’s largest integrated digital supply network, providing real-time information sharing for better patient outcomes, today announced financial and company results for the second quarter of 2019.
Financial growth highlights for Q2 2019 include:
“The TraceLink journey continues to be incredibly exciting. Our digital network platform is quickly expanding, enabling applications that can be built to orchestrate patient-centric business processes and data across the end-to-end healthcare ecosystem – which will truly revolutionize the industry,” said Shabbir Dahod, president and CEO, TraceLink. “As with past quarters, we experienced momentum across all regions as we grow the power of our network, helping customers around the globe navigate various complex requirements while also continuing to innovate on new solutions for the industry.”
Additional Q2 2019 growth highlights and milestones include:
Additional Resources:
Follow TraceLink:
About TraceLink
TraceLink is the world’s largest integrated digital supply network, providing real-time information sharing for better patient outcomes. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. The TraceLink digital supply network is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com.
TraceLink is funded by Georgian Partners, Willett Advisors LLC, Vulcan Capital, Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
View original content to download multimedia:http://www.prnewswire.com/news-releases/tracelink-demonstrates-continued-global-momentum-with-strong-q2-2019-results-300905460.html
SOURCE TraceLink
Toronto, Ontario--(Newsfile Corp. - March 25, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink:…
Bill Increases Funding for Alzheimer’s Research and Prevention EffortsWASHINGTON, March 23, 2024 (GLOBE NEWSWIRE) --…
The first safe therapy with Dr Allen's Device has once again proved its ability to…
Vancouver, British Columbia--(Newsfile Corp. - March 22, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products,…
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt…